IL155371A0 - Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents - Google Patents

Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents

Info

Publication number
IL155371A0
IL155371A0 IL15537101A IL15537101A IL155371A0 IL 155371 A0 IL155371 A0 IL 155371A0 IL 15537101 A IL15537101 A IL 15537101A IL 15537101 A IL15537101 A IL 15537101A IL 155371 A0 IL155371 A0 IL 155371A0
Authority
IL
Israel
Prior art keywords
isothiazole
carboxamide
salts
hyperproliferation agents
hyperproliferation
Prior art date
Application number
IL15537101A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL155371A0 publication Critical patent/IL155371A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL15537101A 2000-11-28 2001-11-19 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents IL155371A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25351300P 2000-11-28 2000-11-28
PCT/IB2001/002193 WO2002044158A1 (en) 2000-11-28 2001-11-19 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents

Publications (1)

Publication Number Publication Date
IL155371A0 true IL155371A0 (en) 2003-11-23

Family

ID=22960587

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15537101A IL155371A0 (en) 2000-11-28 2001-11-19 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents

Country Status (50)

Country Link
US (1) US6831091B2 (xx)
EP (1) EP1337521B1 (xx)
JP (2) JP2004514714A (xx)
KR (2) KR20050116401A (xx)
CN (1) CN1231474C (xx)
AP (1) AP2001002358A0 (xx)
AR (1) AR031512A1 (xx)
AT (1) ATE340786T1 (xx)
AU (2) AU1420402A (xx)
BG (1) BG107752A (xx)
BR (1) BR0115621A (xx)
CA (1) CA2430065C (xx)
CR (1) CR6963A (xx)
CY (1) CY1106240T1 (xx)
CZ (1) CZ20031315A3 (xx)
DE (1) DE60123461T2 (xx)
DK (1) DK1337521T3 (xx)
DO (1) DOP2001000288A (xx)
EA (1) EA005859B1 (xx)
EC (1) ECSP034628A (xx)
EE (1) EE200300247A (xx)
ES (1) ES2271086T3 (xx)
GE (1) GEP20053652B (xx)
GT (1) GT200100237A (xx)
HK (1) HK1059085A1 (xx)
HN (1) HN2001000268A (xx)
HR (1) HRP20030408A2 (xx)
HU (1) HUP0302553A3 (xx)
IL (1) IL155371A0 (xx)
IS (1) IS6788A (xx)
MA (1) MA26960A1 (xx)
MX (1) MXPA03004714A (xx)
MY (1) MY136686A (xx)
NO (1) NO325187B1 (xx)
NZ (1) NZ525788A (xx)
OA (1) OA12532A (xx)
PA (1) PA8533801A1 (xx)
PE (1) PE20020591A1 (xx)
PL (1) PL362079A1 (xx)
PT (1) PT1337521E (xx)
SI (1) SI1337521T1 (xx)
SK (1) SK5862003A3 (xx)
SV (1) SV2002000748A (xx)
TN (1) TNSN01167A1 (xx)
TW (1) TWI287542B (xx)
UA (1) UA74221C2 (xx)
UY (1) UY27039A1 (xx)
WO (1) WO2002044158A1 (xx)
YU (1) YU36403A (xx)
ZA (1) ZA200303341B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
JP2002534468A (ja) 1999-01-13 2002-10-15 バイエル コーポレイション ｐ３８キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2003068229A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
EP2324825A1 (en) 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
BR0312798A (pt) * 2002-07-25 2005-05-03 Pfizer Prod Inc Derivados de isotiazol úteis como agentes anticancerìgenos
AP2005003232A0 (en) * 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
ATE366108T1 (de) 2003-05-20 2007-07-15 Bayer Pharmaceuticals Corp Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten
NZ580384A (en) 2003-07-23 2011-03-31 Bayer Pharmaceuticals Corp 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
RU2317295C1 (ru) * 2003-10-27 2008-02-20 Мерк Энд Ко., Инк. Соль антагониста ccr-2
EP1694686A1 (en) 2003-12-19 2006-08-30 Takeda San Diego, Inc. Kinase inhibitors
WO2005102327A1 (en) * 2004-04-20 2005-11-03 Pfizer Products Inc. Dosage forms and methods of treatment using vegfr inhibitors
JP2007535565A (ja) 2004-04-30 2007-12-06 バイエル ファーマシューティカルス コーポレーション 癌の治療に有用な置換ピラゾリル尿素誘導体
TW200538104A (en) * 2004-05-17 2005-12-01 Pfizer Prod Inc Phenyl derivatives for the treatment of abnormal cell growth
EP1778669A2 (en) 2004-08-18 2007-05-02 Takeda San Diego, Inc. Kinase inhibitors
WO2006044687A2 (en) 2004-10-15 2006-04-27 Takeda San Diego, Inc. Kinase inhibitors
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
SI2044043T2 (sl) 2006-06-16 2021-04-30 H. Lundbeck A/S 1-2(-2,4-dimetilfenilsulfanil)-fenil)piperazin hidrobromid kot spojina s kombinirano aktivnostjo ponovnega privzema serotonina, 5-ht3 in 5-ht1a za zdravljenje kognitivne motnje
US7932390B2 (en) 2006-06-29 2011-04-26 Hoffman-La Roche Inc. Substituted thieno[3,2-C]pyridine carboxylic acid derivatives
BRPI0719883A2 (pt) 2006-10-09 2015-05-05 Takeda Pharmaceutical Inibidores de quinase
MX2010001636A (es) 2007-08-14 2010-03-15 Hoffmann La Roche Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos.
WO2011073521A1 (en) 2009-12-15 2011-06-23 Petri Salven Methods for enriching adult-derived endothelial progenitor cells and uses thereof
CA2806921C (en) 2010-07-23 2019-11-26 Trustees Of Boston University Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
EP2968650B1 (en) * 2013-03-14 2019-01-16 PanOptica, Inc. Ocular formulations for drug-delivery to the posterior segment of the eye
EP3193867B1 (en) * 2014-09-17 2021-01-20 PanOptica, Inc. Ocular formulations for drug-delivery and protection of the anterior segment of the eye

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця

Also Published As

Publication number Publication date
PA8533801A1 (es) 2002-10-31
HRP20030408A2 (en) 2003-08-31
GEP20053652B (en) 2005-11-10
DK1337521T3 (da) 2007-01-29
PE20020591A1 (es) 2002-07-06
DOP2001000288A (es) 2002-12-15
NO20032388L (no) 2003-07-18
WO2002044158A1 (en) 2002-06-06
MXPA03004714A (es) 2003-08-19
HUP0302553A3 (en) 2009-03-30
CY1106240T1 (el) 2011-06-08
AU1420402A (en) 2002-06-11
BR0115621A (pt) 2003-09-02
NZ525788A (en) 2004-11-26
YU36403A (sh) 2006-08-17
EA005859B1 (ru) 2005-06-30
ECSP034628A (es) 2003-07-25
SV2002000748A (es) 2002-12-02
KR20050116401A (ko) 2005-12-12
PT1337521E (pt) 2006-12-29
JP2008056692A (ja) 2008-03-13
NO20032388D0 (no) 2003-05-27
JP4971946B2 (ja) 2012-07-11
MY136686A (en) 2008-11-28
KR20030059275A (ko) 2003-07-07
HK1059085A1 (en) 2004-06-18
MA26960A1 (fr) 2004-12-20
TWI287542B (en) 2007-10-01
GT200100237A (es) 2002-07-03
DE60123461T2 (de) 2007-02-15
CA2430065C (en) 2008-05-20
SI1337521T1 (sl) 2006-12-31
CR6963A (es) 2003-11-25
HN2001000268A (es) 2002-01-30
CZ20031315A3 (cs) 2004-04-14
CN1231474C (zh) 2005-12-14
NO325187B1 (no) 2008-02-11
EP1337521A1 (en) 2003-08-27
TNSN01167A1 (fr) 2005-11-10
CN1476439A (zh) 2004-02-18
SK5862003A3 (en) 2004-05-04
IS6788A (is) 2003-04-14
AR031512A1 (es) 2003-09-24
OA12532A (en) 2006-06-02
UY27039A1 (es) 2002-07-31
HUP0302553A2 (hu) 2003-11-28
AU2002214204B2 (en) 2007-05-24
JP2004514714A (ja) 2004-05-20
CA2430065A1 (en) 2002-06-06
EA200300424A1 (ru) 2003-10-30
UA74221C2 (uk) 2005-11-15
PL362079A1 (en) 2004-10-18
US6831091B2 (en) 2004-12-14
ZA200303341B (en) 2004-04-30
ES2271086T3 (es) 2007-04-16
EP1337521B1 (en) 2006-09-27
ATE340786T1 (de) 2006-10-15
AP2001002358A0 (en) 2001-12-31
EE200300247A (et) 2003-10-15
US20020151573A1 (en) 2002-10-17
DE60123461D1 (de) 2006-11-09
BG107752A (bg) 2004-01-30

Similar Documents

Publication Publication Date Title
IL155371A0 (en) Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
IL178864A0 (en) 3'-prodrugs of 2'-deoxy-??-l-nucleosides
HUP0204118A3 (en) 4-aminopicolinates and their use as herbicides
AU8729901A (en) Benzoylpyrazols and their use as herbicides
GB0303836D0 (en) Oxazolidinones and their use as antibacterial agents
GB0025782D0 (en) Use of inhibitors
HUP0402025A3 (en) Novel bensophenone derivatives or salts thereof and their use
GB0013378D0 (en) Use of therapeutic benzamide derivatives
GB0101035D0 (en) Formulation and use thereof
HUP0300657A3 (en) Herbicidal composition preparation and use thereof
GB0003254D0 (en) Heterocyclic compounds and their therapeutic use
IL151589A0 (en) New combination of a betablocker and a cholestrol-lowering agent
IL150882A0 (en) Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
GB0017518D0 (en) Therapeutic agents
GB0029903D0 (en) Use of anti-muscarinic agents
GB0021497D0 (en) Compounds and their use
GB0007530D0 (en) Trityl-type compounds and their use
SI1259515T1 (en) Thienopyridine derivatives and their use as anti-inflammatory agents
GB0018887D0 (en) Compound and their therapeutic use
IL152474A0 (en) Antihypertensive agents and use
HK1053059A1 (zh) 新用途
GB0027798D0 (en) Use of antimuscarinic agents
GB0018888D0 (en) Compounds and their therapeutic use
GB0018388D0 (en) Pharmaceutically effective compounds and their use
SI1253924T1 (sl) Nitratne soli antimikrobnih sredstev